BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21131428)

  • 21. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
    Gao W; Demirci G; Strom TB; Li XC
    Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
    Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
    Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival.
    Yin N; Zhang N; Xu J; Shi Q; Ding Y; Bromberg JS
    Transplantation; 2011 Jul; 92(1):25-30. PubMed ID: 21508896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival.
    Wang X; Hao J; Metzger DL; Mui A; Ao Z; Verchere CB; Chen L; Ou D; Warnock GL
    Transplantation; 2009 Feb; 87(4):482-90. PubMed ID: 19307783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts.
    Nishihara M; Gotoh M; Ohzato H; Ohta Y; Luo Z; Dono K; Umeshita K; Sakon M; Monden M; Yagita H; Okumura K; Miyasaka M
    Transplantation; 1997 Oct; 64(7):965-70. PubMed ID: 9381542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
    Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
    Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-1/PD-L1 costimulatory pathway-induced mouse islet transplantation immune tolerance.
    Li T; Ma R; Zhu JY; Wang FS; Huang L; Leng XS
    Transplant Proc; 2015; 47(1):165-70. PubMed ID: 25645798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective mobilization of hematopoietic progenitor cells in G-CSF mobilization defective CD26-/- mice through AMD3100-induced disruption of the CXCL12-CXCR4 axis.
    Paganessi LA; Walker AL; Tan LL; Holmes I; Rich E; Fung HC; Christopherson KW
    Exp Hematol; 2011 Mar; 39(3):384-90. PubMed ID: 21168468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
    Lenschow DJ; Zeng Y; Hathcock KS; Zuckerman LA; Freeman G; Thistlethwaite JR; Gray GS; Hodes RJ; Bluestone JA
    Transplantation; 1995 Nov; 60(10):1171-8. PubMed ID: 7482727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression.
    Wang X; Hao J; Leung G; Breitkopf T; Wang E; Kwong N; Akhoundsadegh N; Warnock GL; Shapiro J; McElwee KJ
    J Immunol Res; 2015; 2015():607328. PubMed ID: 26000314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Islet allograft rejection is independent of toll-like receptor signaling in mice.
    Hutton MJ; Westwell-Roper C; Soukhatcheva G; Plesner A; Dutz JP; Verchere CB
    Transplantation; 2009 Nov; 88(9):1075-80. PubMed ID: 19898202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.
    Broxmeyer HE; Orschell CM; Clapp DW; Hangoc G; Cooper S; Plett PA; Liles WC; Li X; Graham-Evans B; Campbell TB; Calandra G; Bridger G; Dale DC; Srour EF
    J Exp Med; 2005 Apr; 201(8):1307-18. PubMed ID: 15837815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of the OX40/OX40L pathway and induction of PD-L1 synergistically protects mouse islet allografts from rejection.
    Li T; Ma R; Zhu J; Wang F; Huang L; Leng X
    Chin Med J (Engl); 2014; 127(14):2686-92. PubMed ID: 25043090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-1/B7-H1 interaction contribute to the spontaneous acceptance of mouse liver allograft.
    Morita M; Fujino M; Jiang G; Kitazawa Y; Xie L; Azuma M; Yagita H; Nagao S; Sugioka A; Kurosawa Y; Takahara S; Fung J; Qian S; Lu L; Li XK
    Am J Transplant; 2010 Jan; 10(1):40-6. PubMed ID: 19889124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic insights into immunomodulation by hepatic stellate cells in mice: a critical role of interferon-gamma signaling.
    Yang HR; Chou HS; Gu X; Wang L; Brown KE; Fung JJ; Lu L; Qian S
    Hepatology; 2009 Dec; 50(6):1981-91. PubMed ID: 19821484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
    Green MM; Chao N; Chhabra S; Corbet K; Gasparetto C; Horwitz A; Li Z; Venkata JK; Long G; Mims A; Rizzieri D; Sarantopoulos S; Stuart R; Sung AD; Sullivan KM; Costa L; Horwitz M; Kang Y
    J Hematol Oncol; 2016 Aug; 9(1):71. PubMed ID: 27535663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TIM4 Regulates the Anti-Islet Th2 Alloimmune Response.
    Vergani A; Gatti F; Lee KM; D'Addio F; Tezza S; Chin M; Bassi R; Tian Z; Wu E; Maffi P; Ben Nasr M; Kim JI; Secchi A; Markmann JF; Rothstein DM; Turka LA; Sayegh MH; Fiorina P
    Cell Transplant; 2015; 24(8):1599-1614. PubMed ID: 24612609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacology of AMD3465: a small molecule antagonist of the chemokine receptor CXCR4.
    Bodart V; Anastassov V; Darkes MC; Idzan SR; Labrecque J; Lau G; Mosi RM; Neff KS; Nelson KL; Ruzek MC; Patel K; Santucci Z; Scarborough R; Wong RS; Bridger GJ; Macfarland RT; Fricker SP
    Biochem Pharmacol; 2009 Oct; 78(8):993-1000. PubMed ID: 19540208
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
    Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
    J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tolerance and prolongation of islet allograft survival by syngeneic hematopoietic stem cell transplantation in mice.
    Yang SF; Xue WJ; Lu WH; Xie LY; Yin AP; Zheng J; Sun JP; Li Y
    Transpl Immunol; 2015 Oct; 33(2):130-9. PubMed ID: 26311302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.